Cargando…
Suppression of a broad spectrum of liver autoimmune pathologies by single peptide-MHC-based nanomedicines
Peptide-major histocompatibility complex class II (pMHCII)-based nanomedicines displaying tissue-specific autoantigenic epitopes can blunt specific autoimmune conditions by re-programming cognate antigen-experienced CD4+ T-cells into disease-suppressing T-regulatory type 1 (TR1) cells. Here, we show...
Autores principales: | Umeshappa, Channakeshava Sokke, Singha, Santiswarup, Blanco, Jesus, Shao, Kun, Nanjundappa, Roopa Hebbandi, Yamanouchi, Jun, Parés, Albert, Serra, Pau, Yang, Yang, Santamaria, Pere |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517389/ https://www.ncbi.nlm.nih.gov/pubmed/31089130 http://dx.doi.org/10.1038/s41467-019-09893-5 |
Ejemplares similares
-
Th Cells Promote CTL Survival and Memory via Acquired pMHC-I and Endogenous IL-2 and CD40L Signaling and by Modulating Apoptosis-Controlling Pathways
por: Umeshappa, Channakeshava Sokke, et al.
Publicado: (2013) -
Bluetongue virus – 23 stimulates inducible nitric oxide synthase expression and nitric oxide production in mononuclear cells of blood and/or regional lymphoid organs
por: Umeshappa, Channakeshava Sokke, et al.
Publicado: (2012) -
CD154 and IL-2 Signaling of CD4(+) T Cells Play a Critical Role in Multiple Phases of CD8(+) CTL Responses Following Adenovirus Vaccination
por: Sokke Umeshappa, Channakeshava, et al.
Publicado: (2012) -
Re-programming mouse liver-resident invariant natural killer T cells for suppressing hepatic and diabetogenic autoimmunity
por: Umeshappa, Channakeshava Sokke, et al.
Publicado: (2022) -
Peptide-MHC-Based Nanomedicines for the Treatment of Autoimmunity: Engineering, Mechanisms, and Diseases
por: Serra, Pau, et al.
Publicado: (2021)